918²©ÌìÌÃ

ͼƬÃû³Æ

ÐÂÎÅ×ÊѶ

ÕãÒ½¶ùÔºÍŶÓ×îÐÂÑо¿Ð§¹û£ºÊ¯É¼¼î¼×ÓÐÍûÖÎÁÆÌÇÄò²¡Éö²¡

ÈÕÆÚ£º

2024Äê10ÔÂ26ÈÕ 08:51


½üÆÚ£¬£¬£¬£¬£¬£¬ £¬ÓÉÕã½­´óѧҽѧԺÁ¥Êô¶ùͯҽԺÉöÄÚ¿ÆÍŶÓÓë918²©ÌìÌÃÏàÖú¿ªÕ¹µÄʯɼ¼î¼×ÖÎÁÆÌÇÄò²¡Éö²¡µÄ¶à×éѧÆÊÎöÑо¿½ÒÏþÁË×îÐÂÑо¿Ð§¹û£¬£¬£¬£¬£¬£¬ £¬Ñо¿Åú×¢Îúʯɼ¼î¼×ÔÚ¼õÇáÌÇÄò²¡ÓÕµ¼µÄÉöËðÉË¡¢Ö¬ÖÊ´úлÔÓÂÒºÍÑ×Ö¢·½ÃæÏÔʾ³öÓÐÏ£ÍûµÄÖÎÁƹ¦Ð§¡£¡£¡£¡£¡£¡£¸ÃÑо¿ÒѽÒÏþÓÚ¡¶Pharmacological Research¡·ÔÓÖ¾£¬£¬£¬£¬£¬£¬ £¬È«ÃûΪ“Huperzine A targets Apolipoprotein E: A potential therapeutic drug for diabetic nephropathy based on omics analysis”¡£¡£¡£¡£¡£¡£

ÔçÔÚ2020Ä꣬£¬£¬£¬£¬£¬ £¬Õã½­´óѧҽѧԺÁ¥Êô¶ùͯҽԺ¾ÍÓë918²©ÌìÌÃÏàÖú¿ªÕ¹¹ýÑÎËáä强ÐÂÆ¬¶Ô¶ùͯÐÂÐ͹Ú×´²¡¶¾Ñ¬È¾µÄÁÆÐ§¼°Çå¾²ÐÔÆÀ¼ÛÑо¿¡£¡£¡£¡£¡£¡£ÏÖÔÚÔÙ´ÎÁªÊÖ£¬£¬£¬£¬£¬£¬ £¬ÓÖÔÚÐµļ²²¡ÁìÓòÈ¡µÃÁËϲÈ˵ÄЧ¹û¡£¡£¡£¡£¡£¡£

 

ʯɼ¼î¼×£º×ÔÈ»À¡ÔùµÄ¶àÃæÄÜÊÖ

ʯɼ¼î¼×(Huperzine A£¬£¬£¬£¬£¬£¬ £¬Hup A)×÷ΪÑÇÖÞÖ²ÎïÉß×ãʯɼµÄÌáÈ¡ÎïÁÙ´²Ö÷ÒªÓÃÓÚÉñ¾­ÍËÐÐÐÔ²¡ÖÎÁÆ£¬£¬£¬£¬£¬£¬ £¬µ«½üÄêÀ´Ñо¿·¢Ã÷ÆäÔÚÌÇÄò²¡ÊÓÍøÄ¤²¡±äÖоßÓÐÏÔÖøµÄ½µÑªÌǺͿ¹Ñ××÷Óᣡ£¡£¡£¡£¡£µ«Æä¸üÆÕ±éµÄ±£»£»£»£»£»¤×÷Ó㬣¬£¬£¬£¬£¬ £¬ÌØÊâÊǶÔÌÇÄò²¡ÁíÒ»²¢·¢Ö¢ÌÇÄò²¡Éö²¡Éö¹¦Ð§µÄ±£»£»£»£»£»¤×÷ÓÃÈÔδ±»Ñо¿¡£¡£¡£¡£¡£¡£

 

ÌÇÄò²¡Éö²¡£¡£¡£¡£¡£¡£ºÇÄȻDZÔڵĿµ½¡É±ÊÖ

ÌÇÄò²¡£¡£¡£¡£¡£¡£¨DM£©×÷Ϊ³£¼û²¡¡¢¶à·¢²¡£¡£¡£¡£¡£¡£¬£¬£¬£¬£¬£¬ £¬ÊÇÑÏÖØÍþвÈËÀ࿵½¡µÄÌìÏÂÐÔ¹«¹²ÎÀÉúÎÊÌâ¡£¡£¡£¡£¡£¡£ÏÖÔÚÔÚÌìϹæÄ£ÄÚ£¬£¬£¬£¬£¬£¬ £¬ÌÇÄò²¡»¼²¡Âʺͻ¼²¡ÈËÊý¼±¾çÉÏÉý£¬£¬£¬£¬£¬£¬ £¬¾Ý¹ú¼ÊÌÇÄò²¡Í¬ÃË£¨IDF£©Í³¼Æ£º2021ÄêÈ«Çò³ÉÄêÌÇÄò²¡ÈËÊýÒÑ´ï5.37ÒÚ£¬£¬£¬£¬£¬£¬ £¬½Ï2019ÄêÔöÌí½ü16%£¬£¬£¬£¬£¬£¬ £¬Ô¤¼Æµ½2045ÄêÈ«ÇòÌÇÄò²¡»¼²¡×ÜÈËÊý½«µÖ´ï7.83ÒÚ£»£»£»£»£»2021ÄêÈ«ÇòÒòÌÇÄò²¡éæÃüÈËÊý´ï670Íò¡£¡£¡£¡£¡£¡£

½ü40¶àÄêÀ´£¬£¬£¬£¬£¬£¬ £¬Ëæ×ÅÎÒ¹ú¾­¼Ã¸ßËÙÉú³¤¡¢ÉúÑÄ·½·¨Î÷·½»¯¡¢¶¼»á»¯ºÍÉú³ÝÀÏÁ仯¡¢·ÊÅÖÂÊÉÏÉý£¬£¬£¬£¬£¬£¬ £¬ÎÒ¹úÌÇÄò²¡»¼²¡ÂÊÒ²³Ê¿ìËÙÔöÌíÇ÷ÊÆ£º1980ÄêÎÒ¹ú³ÉÈËÌÇÄò²¡»¼²¡ÂÊΪ0.67%£¬£¬£¬£¬£¬£¬ £¬2007 Äê´ï9.7%£¬£¬£¬£¬£¬£¬ £¬2017Äê¸ü¸ß´ï 11.7%¡£¡£¡£¡£¡£¡£ÌÇÄò²¡Ç°ÆÚµÄ±ÈÀý¸ü¸ß¡£¡£¡£¡£¡£¡£¸üΪÑÏÖØµÄÊÇÎÒ¹úÔ¼ÓÐ50%µÄÌÇÄò²¡Î´±»Õï¶Ï£»£»£»£»£»°ÕÁ˽ÓÊÜÖÎÁÆÕߣ¬£¬£¬£¬£¬£¬ £¬ÌÇÄò²¡¿ØÖÆ×´Ì¬Ò²²»²ÇÏë¡£¡£¡£¡£¡£¡£IDFÊý¾ÝÏÔʾ£¬£¬£¬£¬£¬£¬ £¬×èÖ¹2021ÄêÎÒ¹ú³ÉÈËÌÇÄò²¡ÊýĿΪ1.41ÒÚ¡£¡£¡£¡£¡£¡£ÎÒ¹úÒÑÈ»³ÉΪȫÌìÏÂÌÇÄò²¡»¼Õß×î¶àµÄ¹ú¼Ò¡£¡£¡£¡£¡£¡£

¶øÌÇÄò²¡Éö²¡(diabetic nephropathy£¬£¬£¬£¬£¬£¬ £¬DN)ÊÇÌÇÄò²¡×îÖ÷ÒªÇÒ×îÑÏÖØµÄ²¢·¢Ö¢Ö®Ò»£¬£¬£¬£¬£¬£¬ £¬·¢²¡»úÖÆÖØ´ó£¬£¬£¬£¬£¬£¬ £¬Éæ¼°Ñõ»¯Ó¦¼¤¡¢Ñ×Ö¢¡¢ÏËά»¯ºÍϸ°ûµòÍö£¬£¬£¬£¬£¬£¬ £¬ÁÙ´²ÌØÕ÷ΪһÁ¬ÐÔ°×ÂѰ×ÄòÉøÍ¸ÔöÌí£¬£¬£¬£¬£¬£¬ £¬ÉöСÇòÂ˹ýÂÊ£¨eGFR£©¾ÙÐÐÐÔϽµ£¬£¬£¬£¬£¬£¬ £¬×îÖÕÉú³¤ÎªÖÕÄ©ÆÚÉö²¡£¡£¡£¡£¡£¡£¨ESRD£©£¬£¬£¬£¬£¬£¬ £¬½ìʱÉöÔ๦Ч»ù±¾Ëðʧ£¬£¬£¬£¬£¬£¬ £¬ÑݱäΪÉöË¥½ß£¬£¬£¬£¬£¬£¬ £¬ÌåÄÚ·ºÆð´ó×Ú¶¾ËØ»ýÖü£¬£¬£¬£¬£¬£¬ £¬Ë®¡¢µç½âÖÊ¡¢Ëá¼îʧºâ£¬£¬£¬£¬£¬£¬ £¬ÖÂËÀÂʸߣ¬£¬£¬£¬£¬£¬ £¬Ê®·ÖΣÏÕ¡£¡£¡£¡£¡£¡£

¹ØÓÚÌÇÄò²¡Éö²¡£¡£¡£¡£¡£¡£¬£¬£¬£¬£¬£¬ £¬ÏÖÔÚµÄÁÙ´²ÖÎÁÆÈÔÒÔÔçÆÚ¿ØÖÆÑªÌÇ¡¢ÑªÑ¹ÎªÖ÷£¬£¬£¬£¬£¬£¬ £¬¾ÙÐÐÖÁÍíÆÚÔòÐèÒª½ÓÄÉ͸ÎöµÈÉöÔàÌæ»»ÁÆ·¨¾ÙÐÐÖÎÁÆ¡£¡£¡£¡£¡£¡£ÉÐÎÞÓÐÓõÄÒ©Îï¸ÉÔ¤ÊֶΡ£¡£¡£¡£¡£¡£

 

¶à×éѧÆÊÎö£ºÕ¹ÏÖʯɼ¼î¼×µÄ×÷ÓûúÖÆ

±¾´ÎÑо¿ÖУ¬£¬£¬£¬£¬£¬ £¬Ñо¿Ö°Ô±½ÓÄÉÁËת¼×é¡¢´úл×顢΢ÉúÎï×éºÍÍøÂçÒ©ÀíѧµÈ¶à×é±ð¶àѧ¿Æ×ÛºÏÆÊÎöÒªÁ죬£¬£¬£¬£¬£¬ £¬Ì½ÌÖÁËʯɼ¼î¼×¹ØÓÚÌÇÄò²¡Éö²¡µÄÖÎÁÆ×÷Óᣡ£¡£¡£¡£¡£Ñо¿Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬£¬ £¬Ê¯É¼¼î¼×Äܹ»Í¨¹ýµ÷¿ØApoEµÄ±í´ï£¬£¬£¬£¬£¬£¬ £¬Æðµ½±£»£»£»£»£»¤ÉöÔà¡¢µ÷Àí´úл¡¢¸ÄÉÆ³¦µÀ΢ÉúÎïȺ¡¢¸ÄÉÆÑ×Ö¢µÈ×÷Óᣡ£¡£¡£¡£¡£¸ÃÑо¿Ê×´ÎÌṩÁËʯɼ¼î¼×¶ÔDNÖÎÁÆ×÷ÓõÄÖ¤¾Ý£¬£¬£¬£¬£¬£¬ £¬Åúעʯɼ¼î¼×¿ÉÄÜͨ¹ý°ÐÏòµ÷¿ØApoE£¬£¬£¬£¬£¬£¬ £¬³ÉΪһÖÖDZÔÚµÄÔ¤·ÀºÍÖÎÁÆDNµÄÒ©Îï¡£¡£¡£¡£¡£¡£ÏêϸÈçÏ£º

1.  ÉöÔà±£»£»£»£»£»¤×÷ÓãºÔÚÁÙ´²ÖУ¬£¬£¬£¬£¬£¬ £¬ÄòÂѰ×ÊÇÆÀ¹ÀÉö¹¦Ð§ºÍËðÉË¡¢ÌáÐÑÉöÔ༲²¡µÄÖ÷ÒªÖ¸±ê¡£¡£¡£¡£¡£¡£Ñо¿Åú×¢£¬£¬£¬£¬£¬£¬ £¬ÔÚÐÛÐÔSD´óÊó¸øÒ©Ê¯É¼¼î¼×ºó£¬£¬£¬£¬£¬£¬ £¬Óë±ÈÕÕµÄδʹÓÃʯɼ¼î¼×µÄDN´óÊóÏà±È£¬£¬£¬£¬£¬£¬ £¬Ê¹ÓÃÁËʯɼ¼î¼×µÄDN´óÊóÄòÂѰף¨uALB£©Ë®Æ½·ºÆð½µµÍ£¬£¬£¬£¬£¬£¬ £¬²¢ÇÒÆäÉöÔàÖ¸Êý£¨kidney index£©¡¢Ñª¼¡ôû£¨SCr£©¡¢ÄòËØµª£¨BUN£©Ë®Æ½½ÔÓиÄÉÆ¡£¡£¡£¡£¡£¡££¨ÈçÏÂͼ£©

£¨×¢£ºNCΪÕý³£´óÊ󣻣»£»£»£»DNΪ»¼DN´óÊ󣻣»£»£»£»DN+Hup AΪʹÓÃÊÇʯɼ¼î¼×µÄDN´óÊ󡣡£¡£¡£¡£¡££©

 

 

ÁíÍ⣬£¬£¬£¬£¬£¬ £¬´óÊóÉöСÇò£¨Glomerulus£©ºÍÉöС¹Ü£¨Renal tubule£©µÄ½á¹¹ËðÉËÔÚʯɼ¼î¼×ÖÎÁÆÏÂÒ²ÓÐËù¼õÇᣬ£¬£¬£¬£¬£¬ £¬Î¬³ÖÕý³£ÉöСÇòÂ˹ý¹¦Ð§Ëù±ØÐèµÄÉö²¡ÂѰף¨Nephrin£©ºÍ×ãÍ»ÂѰף¨Podocin£©µÄÂѰ×ÖÊˮƽÔÚʯɼ¼î¼×¸øÒ©ºóÒ²ÏÔÖø»ØÉý¡£¡£¡£¡£¡£¡£

±ÈÕÕδÓÃÒ©µÄDN´óÊ󣬣¬£¬£¬£¬£¬ £¬Ê¹ÓÃʯɼ¼î¼×ºóµÄ´óÊóÉöÔ๦Чָ±êÒÔ¼°½á¹¹ËðÉËÔÚʹÓÃʯɼ¼î¼×ºó»ù±¾¶¼ÓÐËù¸ÄÉÆ¡£¡£¡£¡£¡£¡£Òò´Ë¿ÉÒԵóö£¬£¬£¬£¬£¬£¬ £¬Ê¯É¼¼î¼×±£´æ×ŶÔÉöÔàµÄ±£»£»£»£»£»¤×÷Óᣡ£¡£¡£¡£¡£

2.  »ùÒò±í´ïÓ°Ï죺ΪÁË̽Ë÷ʯɼ¼î¼×ÖÎÁÆDNµÄ·Ö×Ó»úÖÆ£¬£¬£¬£¬£¬£¬ £¬Ñо¿¶ÔÉöÔà×éÖ¯¾ÙÐÐÁËת¼×é²âÐòºÍ²î±ð±í´ï»ùÒò(DEG)ÆÊÎö¡£¡£¡£¡£¡£¡£Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬£¬ £¬ÔÚDN×éÖÐÏÔÖøÉϵ÷µÄApoEºÍApoC 2ÔÚʯɼ¼î¼×ÖÎÁƺóÏÔÖø½µµÍ¡£¡£¡£¡£¡£¡£

3.  ´úлÎïµ÷Àí£ºÑо¿Í¨¹ýÖ÷ÒòËØÆÊÎö£¨PCA£©ºÍÆ«×îС¶þ³ËÅбðÆÊÎö£¨PLS-DA£©À´Ñо¿ÉöÔà´úлת±ä·¢Ã÷£¬£¬£¬£¬£¬£¬ £¬NC×éºÍDN×éµÄÑùÆ·¾ßÓÐÏÔ×ÅÊèÉ¢ÐÔ£¬£¬£¬£¬£¬£¬ £¬¶øDN+Hup AµÄÂþÑܸü¿¿½üNC×é¡£¡£¡£¡£¡£¡£ÕâÒ²¾ÍÒâζ×Å£¬£¬£¬£¬£¬£¬ £¬Ê¹ÓÃÁËʯɼ¼î¼×µÄDN´óÊóµÄÉöÔà´úлÏà±ÈÓÚδÓÃÒ©µÄDN´óÊ󣬣¬£¬£¬£¬£¬ £¬ÆäÉöÔà´úлԽ·¢¿¿½üÓÚÕý³£´óÊ󡣡£¡£¡£¡£¡£ÕâÅúעʯɼ¼î¼×ÖÎÁÆÒ»¶¨Ë®Æ½Éϻָ´ÁËDN´óÊóµÄ´úл¡£¡£¡£¡£¡£¡££¨ÈçÏÂͼ£©

 

4.  ³¦µÀ΢ÉúÎïȺ¸ÄÉÆ£ºShannonÖ¸ÊýÊÇÆÀ¹À΢ÉúÎïȺÂä¶àÑùÐÔ»ò¸»ºñ¶ÈµÄ³£ÓÃÖ¸±ê£¬£¬£¬£¬£¬£¬ £¬ÊýÖµÔ½¸ßÅúעȺÂäµÄ¶àÑùÐÔÔ½¸ß£¬£¬£¬£¬£¬£¬ £¬¹ÊÑо¿ÓÃÆäÀ´ÆÀ¹Àʯɼ¼î¼×¶Ô´óÊ󳦵À΢ÉúÎïȺµÄÓ°Ïì¡£¡£¡£¡£¡£¡£Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬£¬ £¬DN×éµÄShannon¶àÑùÐÔÖ¸Êý½µµÍ£¬£¬£¬£¬£¬£¬ £¬¶øDN+Hup A×éµÄShannon¶àÑùÐÔÖ¸ÊýÔöÌí£¬£¬£¬£¬£¬£¬ £¬Åúעʯɼ¼î¼×´¦Öóͷ£µ÷ÀíÁË´óÊ󳦵À΢ÉúÎïȺ¶àÑùÐÔ¡£¡£¡£¡£¡£¡££¨ÈçÏÂͼ£©

 

 

 

ÁÙ´²ÒâÒ壺ApoE×÷ΪÉúÎï±ê¼ÇÎï

Ϊ̽ÌÖApoEÓëDNÏà¹ØÉúÎï±ê¼ÇÎïµÄÁÙ´²Ïà¹ØÐÔ£¬£¬£¬£¬£¬£¬ £¬Ñо¿ÄÉÈëÁË428ÀýDN»¼Õß¾ÙÐнøÒ»²½ÆÊÎö¡£¡£¡£¡£¡£¡£

ÌÇ»¯ÑªºìÂѰף¨HbA1c£©ÊÇѪÌÇ¿ØÖÆË®Æ½µÄÖ÷ÒªÖ¸±ê£¬£¬£¬£¬£¬£¬ £¬Í¨³£ÒÔΪ£¬£¬£¬£¬£¬£¬ £¬ÌÇ»¯ÑªºìÂѰ×Ũ¶È¿ÉÓÐÓõط´Ó¦ÒÑÍù8~12ÖÜÆ½¾ùѪÌÇˮƽ¡£¡£¡£¡£¡£¡£Ñо¿·¢Ã÷£¬£¬£¬£¬£¬£¬ £¬HbA1cÓëApoE³ÊÕýÏà¹Ø£¬£¬£¬£¬£¬£¬ £¬ÌáÐÑApoEµÄ±í´ïËæHbA1cˮƽµÄÉý¸ß¶øÔöÌí¡£¡£¡£¡£¡£¡£

ÔÚÉö¹¦Ð§·½Ã棬£¬£¬£¬£¬£¬ £¬ÔÚ¸ßÂѰ×ÄòˮƽÏ£¬£¬£¬£¬£¬£¬ £¬ApoE±í´ïÓë24 hÄòÂѰ×ˮƽ³ÊÇ¿ÕýÏà¹Ø£¬£¬£¬£¬£¬£¬ £¬Åú×¢Ëæ×ÅÂѰ×ÄòˮƽµÄÉý¸ß£¬£¬£¬£¬£¬£¬ £¬ApoE±í´ïÒ²Éý¸ß¡£¡£¡£¡£¡£¡£

ÁíÍ⣬£¬£¬£¬£¬£¬ £¬Ñо¿»¹·¢Ã÷£¬£¬£¬£¬£¬£¬ £¬ApoEÓëѪÇå°×ÂѰף¨ALB£©¡¢Ö¬ÖÊÉúÎï±ê¼ÇÎï¡¢Ñ×Ö¢±ê¼ÇÎÓÈÆäÊÇCRPºÍHsCRP£©µÈ¶¼±£´æ½ÏΪÏÔÖøµÄÏà¹ØÐÔ¡£¡£¡£¡£¡£¡££¨ÈçÏÂͼ£©

 

 

Ñо¿»¹¾ÙÐÐÁËApoEÇõÍÑéÖ¤£¬£¬£¬£¬£¬£¬ £¬Çõͺóµ¼ÖÂÑ×Ö¢¼õÇᡢϸ°ûÕ³¸½ÔöÌíºÍϸ°û»îÐÔÉý¸ß¡£¡£¡£¡£¡£¡£ÓëNC×éÏà±È£¬£¬£¬£¬£¬£¬ £¬ÇõÍ×éÖÐ×ÔÊÉÌå±ê¼ÇÎïLC 3B II/LC 3B IÂѰױí´ïÏÔÖø½µµÍ£¬£¬£¬£¬£¬£¬ £¬Åú×¢ÆÏÌÑÌÇÓÕµ¼¸ü¸ßµÄ×ÔÊÉˮƽ£¬£¬£¬£¬£¬£¬ £¬ÇõÍApoE½µµÍ×ÔÊÉˮƽ¡£¡£¡£¡£¡£¡£

 

ÍøÂçÒ©Àíѧ£ºÑé֤ʯɼ¼î¼×µÄ¶à°Ðµã×÷ÓÃ

ͨ¹ýÍøÂçÒ©ÀíѧÆÊÎö£¬£¬£¬£¬£¬£¬ £¬Ñо¿Ö°Ô±½øÒ»²½ÑéÖ¤ÁËʯɼ¼î¼×¿ÉÄÜͨ¹ý°ÐÏòµ÷¿Ø¶à¸öÓëDNÏà¹ØµÄ»ùÒòºÍ´úл;¾¶À´Ê©Õ¹×÷ÓÃ, ²¢ÇÒÄܹ»Í¨¹ý¿ØÖÆÏ¸°ûµòÍö¶øÆð±£»£»£»£»£»¤×÷Óᣡ£¡£¡£¡£¡£

 

½áÂÛ£ºÊ¯É¼¼î¼×µÄDZÁ¦ÓëδÀ´Ñо¿Æ«Ïò

¸ÃÑо¿Ê×´ÎÌṩÁËʯɼ¼î¼×¶ÔDNÖÎÁÆ×÷ÓõÄÖ¤¾Ý£¬£¬£¬£¬£¬£¬ £¬Åúעʯɼ¼î¼×¿ÉÄÜͨ¹ý°ÐÏòµ÷¿ØApoE£¬£¬£¬£¬£¬£¬ £¬³ÉΪһÖÖDZÔÚµÄÔ¤·ÀºÍÖÎÁÆDNµÄÒ©Îï¡£¡£¡£¡£¡£¡£Ö»¹ÜÑо¿È¡µÃÁËÁîÈ˹ÄÎèµÄЧ¹û£¬£¬£¬£¬£¬£¬ £¬µ«ÈÔÐè½øÒ»²½µÄÁÙ´²ÊÔÑéºÍ´ó¹æÄ£¶à×éѧÊý¾ÝÑéÖ¤À´ÆÀ¹Àʯɼ¼î¼×µÄÁÙ´²ÖÎÁÆÇ±ÄÜ¡£¡£¡£¡£¡£¡£

ÌÇÄò²¡Éö²¡µÄÖÎÁÆÊÇÒ»¸öÖØ´óµÄÀú³Ì£¬£¬£¬£¬£¬£¬ £¬µ«ÕâÏîÑо¿ÎªÎÒÃÇÌṩÁËеÄÊӽǺÍÏ£Íû¡£¡£¡£¡£¡£¡£Ëæ×ÅÑо¿µÄÉîÈ룬£¬£¬£¬£¬£¬ £¬ÎÒÃÇÆÚ´ýʯɼ¼î¼×Äܹ»³ÉΪÌÇÄò²¡»¼ÕßµÄи£Òô¡£¡£¡£¡£¡£¡£ÈÃÎÒÃÇÒ»Æð¹Ø×¢ÕâÒ»ÁìÓòµÄ×îÐÂÏ£Íû£¬£¬£¬£¬£¬£¬ £¬ÎªÌÇÄò²¡»¼Õß´øÀ´¸ü¶àµÄÏ£ÍûºÍÑ¡Ôñ¡£¡£¡£¡£¡£¡£

 

 

Ñо¿ÎÄÏ×ȪԴ£º

 

 

 

ÉùÃ÷£º

1.±¾ÐÂÎÅÖ¼ÔÚ·ÖÏíѧÊõÇ°ÑØ¶¯Ì¬£¬£¬£¬£¬£¬£¬ £¬½ö¹©Ò½ÁÆÎÀÉúרҵÈËÊ¿»ùÓÚѧÊõÄ¿µÄ²ÎÔÄ£¬£¬£¬£¬£¬£¬ £¬·Ç¹ã¸æÓÃ;¡£¡£¡£¡£¡£¡£

2.918²©ÌìÌÃÖÆÒ©²î³ØÈκÎÒ©Æ·ºÍ/»ò˳Ӧ֢×÷ÍÆ¼ö¡£¡£¡£¡£¡£¡£

Ïà¹ØÍÆ¼ö

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿